Literature DB >> 17622236

Molecular pathways and the hope of targeting angiogenesis.

Cora N Sternberg1.   

Abstract

Year:  2007        PMID： 17622236     DOI： 10.1038/ncpuro0858

Source DB:  PubMed          Journal:  Nat Clin Pract Urol        ISSN： 1743-4270


× No keyword cloud information.
  1 in total

1.  Bevacizumab reduces the growth rate constants of renal carcinomas: a novel algorithm suggests early discontinuation of bevacizumab resulted in a lack of survival advantage.

Authors:  Wilfred D Stein; James Yang; Susan E Bates; Tito Fojo
Journal:  Oncologist       Date:  2008-09-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.